07.19.24 -- Integrating AI And ML Into GMP Settings

Not really into choosing extended time away and exhibit halls over the simple pleasures of summertime? No reason to put your CDMO search on hold – Outsourced Pharma Capacity Update’s PARTNER WEEK is here! Take the travel and headache out of your plans and join us right from your computer. Assess potential fit for your next drug development project in convenient 20-minute segments – all grouped by molecule type. Presenters will share current available capacity across featured capabilities. Register for free.

Consultants coordinating with investors offer an ecosystem around the molecule being developed at a biotech, and help to reevaluate development decisions in a more dispassionate way.” Dispassion applied specifically to ultimate commercial profitability.

Innovations in drug delivery formats are enabling more patient-centric treatments and helping to boost patient compliance. Learn about the advances being developed to expand the potential of ODT technology.

Implementing a cleaning procedure is essential to maintaining tablet tooling and presses. Clean tooling reduces product cross-contamination risk and decreases premature wear. 

Nitrosamines can come from a range of sources, including raw materials, manufacturing processes, and even water sources. Detecting them requires sensitive analytical methods.

Physiologically based pharmacokinetic (PBPK) modeling advancements are helping drug sponsors mitigate risk in preclinical and clinical studies through early identification of poor absorption properties.

Our dedication to quality and safety of energetic chemistry has laid a solid foundation for supplying cGMP high energy compounds to world-leading pharmaceutical companies.

An outsourcing partner with services from the earliest phases of development and formulation to manufacturing and packaging is critical for advancing your product to market with reduced cost and time.

We have an innovative business model that does not add additional costs to your project. Review our network's regulatory starting material capabilities and contact us to simplify your outsourcing solutions.

What's your development and manufacturing outsourcing strategy based on? Do you have the right contracts and external relationships in place to successfully implement that strategy? Are there new models for sponsor-CDMO partnerships? Join Outsourced Pharma Live on August 13th as our panel of professionals will provide personal analysis and ideas for determining how you might best conduct your development and manufacturing activities, outsourcing business models, and external relationships.